Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug

Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such...